TRxADE Group (NASDAQ: MEDS),a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States, has reported its financial numbers for quarter three 2021, the period ended Sept. 30, 2021. Highlights of the report include a revenue increase of 34.3% over Q2 2021. In addition, the company noted that TRxADE Health has added an estimated 250 new registered members in the third quarter, with a total of registered members now reaching almost 13,000, and Bonum Health announced the availability of prepaid digital telemedicine passes, which offers uninsured consumers an innovative way to gain access to vital healthcare services. The company plans to host a conference call this afternoon at 5 p.m. ET to discuss the financial report; the call will include a question-and-answer portion. To participate, U.S. callers should dial 1-877-425-9470; international callers should dial 1-201-389-0878. All callers should use Conference ID 13723384. The call will also be available via webcast. “We saw strong margin improvement as our revenue base returned to the core TRxADE pharmaceutical exchange platform in the third quarter, seeing a drop-off in the one-time personal protective equipment sales recognized in 2020, which were driven by the initial onset of the COVID-19 pandemic,” said TRxADE Health chair and CEO Suren Ajjarapu in the press release. “Our nationwide footprint continues to grow, and we have relentlessly focused on exciting new ways to expand proportional wallet-share within our large, growing network of registered users, while better enabling them to service their respect customers — the end users — further growing their loyalty to their local retail pharmacy. Our telehealth subsidiary Bonum Health has continued to grow, building a foundation that we believe we can build upon for years to come. . . . In summary, we are focusing [on] new strategic partnerships to drive forward our core business while diversifying our revenue base and leveraging our existing strengths through Bonum Health. Taken as a whole, we believe we are building an incredibly compelling healthcare ecosystem, allowing consumers access to affordable healthcare while building an exciting value proposition for our shareholders.”
To view the webcast, visit https://ibn.fm/ZMnt8
To view the full press release, visit https://ibn.fm/RQeP7
About Trxade Group Inc.
Trxade Group is a health-services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the United States. The company operates the TRxADE drug-procurement marketplace serving a total of 12,950-plus members nationwide and fostering price transparency as well as the Bonum Health brand, offering patient centric telehealth services. For more information about the company, please visit www.Trxade.com and www.BonumHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
